Rituximab in CD20 positive multiple myeloma

Leukemia. 2008 May;22(5):1082-3. doi: 10.1038/sj.leu.2405010. Epub 2007 Nov 1.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Remission Induction
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Rituximab